Clinical characteristics of 97 patients with epilepsy associated with a small single cerebral calcific CT lesion (SSCCCTL), measuring 20 mm or less were analysed. The mean age was 20 years and 60% were in the first and second decades. Eighteen (18.5%) patients had a previous history of unprovoked seizures, with complex partial seizures (61%) being the most common type. Seizures could be localized to a single ILAE site in 73% of patients. None bad neurological deficit and electroencephalograph abnormalities were noted in 29% of patients. Fifty-one (53%) patients had breakthrough seizures and were more common with frontal location. By 7 years 71.5% (95% confidence intervals (CI) 53.7-85.4) of patients achieved 3-year remission and 66% (CI 32.4-88.2) had achieved 5-year remission. The clinical pattern of the seizures was clearly distinctive to allow it to be localized to the location of the lesion on computerized tomography (CT) scan in 25 (26%) patients and in another 31 (31%) patients nearer to the anatomical site of the lesion on the CT scan. There was discordance between clinical localization and CT location of the lesion in 15 patients. Nine of the l0 patients with occipital or parietooccipital location had focal tonic-clonic seizures with secondary generalization. Both patients with temporal location had motor seizures. The relevance of these findings to the seizure propagation was discussed. 
INTRODUCTION
A single small cerebral calcific lesion measuring 20 mm or less, is one of the more common findings seen in CT brains of patients with epilepsy in the geographical areas where neurocysticercosis is endemic and forms one of the aetiological factors for symptomatic localization related epilepsy 1-6. This CT morphology represents the end stage in the natural history of parenchymal cysticercal cyst 5-9. There are no published reports on clinical characteristics and longterm prognosis of epilepsy associated with small single cerebral calcific CT lesions (SSCCCTL). The aim of the present study is to address this issue.
MATERIAL AND METHODS
The study material consisted of patients with a SSCC-CTL who had seizures as a presenting symptom. The SSCCCTL was defined as a single circular or oval calcific lesion measuring 20 mm or less without surrounding gliosis (Fig. 1 ). Patients were investigated for any other possible cause for epilepsy before they were included in the study.
Information recorded from the case records included: date of first seizure, date of registration with the epilepsy clinic, date of index seizure, type of seizure I°, localization of the seizure based on the seizure semiology II, electroencephalographic (EEG) abnormalities, family history of epilepsy, previous history of febrile convulsions and unprovoked seizures, neurological findings and treatment information prior to registration. The CT location of the lesion was also recorded. Follow-up information recorded included seizure recurrence and the possible factors and circumstances for recurrence, any change in medication and any new neurological or medical developments if any. The interval between discontinuation of antiepileptic drugs (AED) and relapse of seizures was also noted.
All patients began monotherapy with unselected drugs at standard daily doses. Poor seizure control and/or relevant drug toxicity were required for dose 1059-1311198/020153 + 05 $12.00/0 ~ 1998 British Epilepsy Association adjustments or subsequent drug changes. Changes consisted of a switch to another monotherapy or addition of a second drug. Therapeutic drug monitoring was not routinely carried out. Remission was defined as a seizure-free period. Remission rates were calculated by actuarial analysis 12 with 95% confidence intervals (CI). The cumulative proportion of patients ever attaining a 3-or 5-year remission was calculated from the index seizure as many patients were not on any AED medication before registration. The index seizure was defined as the seizure that caused the patient to register with the epilepsy clinic. Frequency of breakthrough seizures were also recorded in all patients. Breakthrough seizures were defined as seizures occurring after medication was prescribed but before attaining remission for those patients who were seizure free for a sufficient period 13.
R E S U L T S Clinical features
There were 97 patients with SSCCCTL. Their mean age was 20 years (range 6--70 years). The age distribution is shown in Fig. 2 , with 58 (60%) patients in (Table 2 ).
EEG and neuroimaging findings
Abnormalities in 28 (29%) patients were shown by EEG. Focal spike-or sharp-wave activity with or without secondary generalization was seen in 14 of these records, and of the remaining 14 patients focal slowing was seen in 12 and generalized slowing in two records. The location of the lesion on CT scan was on the fight side in 39 (40%) patients and on the left side in 58 (60%) patients. The parietal lobe was the site in 41 (42%) patients followed by the frontal lobe in 17 (18%) patients.
Breakthrough seizures while receiving AED treatment
Breakthrough seizures were seen in 51 (53%) patients. There was no correlation between the number of breakthrough seizures before complete control and the number of pretreatment seizures. Breakthrough seizures were more common in patients with clinical features suggestive of frontal-lobe origin (Table 3) . 
Remission and relapses
By 7 years, 71.5% (95% CI 53.7-85.4) of patients had achieved a 3-year remission, and 66% (95% CI 32.4-88.2) had achieved a 5-year remission. All four patients in whom seizure semiology was suggestive of temporal-lobe origin continued to have seizures. Antiepileptic drugs were withdrawn in 27 patients who had been seizure free for 2-5 years. Twentythree patients (85%) relapsed at an interval of 9-46 months. The mean duration of follow-up was 20.3 months (range 6--46 months). The response to AED after relapse, however, was good, and these patients remained free of seizures for several months of further follow-up.
Computerized tomography location of lesion and seizure localization
The clinical pattern of seizures was clearly distinctive to allow it to be localized to the site of the lesion on the CT scan in 25 (26%) patients. In 31 (32%) patients the location of the CT lesion was nearer to the location of the anatomical site to which seizure semiology could be localized. In these 31 patients the location of the lesion was in the parietal lobe nearer to the motor strip and all of them had tonic--clonic seizures. In another 15 (15%) patients the location of the lesion on the CT scan was remote from the anatomical localization of seizures by clinical features. In the remaining 26 (27%) patients the seizure was unlocalized (Table 4 ). In 18 of them the lesion was located on CT in the frontal lobe or in the parietal lobe nearer to the motor strip. In the remaining eight patients the lesion was located in the occipital lobe.
Of the 10 patients with occipital or parieto-occipital location 9 had focal tonic-clonic seizures with secondary generalization. Three patients with parietal location had clinical features suggestive of temporallobe epilepsy. Both of the patients with temporal location had focal tonic--clonic seizures with secondary generalization (Table 5) .
DISCUSSION
A parenchymal cysticercal cyst in the brain passes through four stages in its natural evolution 7. The stages are vesicular, colloid, granulonodular and calcific. The majority of patients with parenchymal lesions become symptomatic during granulonodular and calcific stages 8"9. Seizure is the common mode of presentation during the calcific stage. Seizures associated with SSCCCTL can be of any type and neurological examination is often normal 14. This study showed that remission rates are similar to any remote symptomatic epilepsy 15. Other important clinical characteristics seen in these patients included a high incidence of breakthrough seizures before remission and a high rate of relapse following the withdrawal of antiepileptic medication.
The size of the lesion in these patients was very small measuring between 5 and 20 mm, more often less than 10 mm. This is likely to allow precise localization of the seizure phenomenon by the onset and spread. Clinical features form the basis of localization in the ILAE classification 11. However, in clinical practice, it is not always possible to localize to one anatomical site epilepsies which are localization related. In the National General Practice Study of Epilepsy only 24% of localization-related epilepsies could be clinically localized to a single ILAE proposed site of origin 16. Whereas seizure semiology often allows localization of seizures to one larger cerebral region 16--18. Discordance between clinical localization based on seizure semiology and location of the lesion on neuroimaging is not an uncommon feature in patients with symptomatic localization-related epilepsies 16' t8 Of the 41 patients with parietal location of the lesion only three had a sensory onset. In 31 patients the lesion was nearer to the motor strip and in seven localization was not possible to one anatomical site. This discordance between clinical localization and location of the lesion on neuroimaging probably reflects the spread of seizure discharges. Earlier clinical studies stress that patients with seizures originating in the occipital lobe can present with confusing complex ictal patterns that can lead to localization errors ~9, 20. Ajmone-Marsan and Ralston 2 I stated that 'discharges arising from the visual region may possess the greater potentiality for complexity of seizure formation'. They predicted that seizures originating in the occipital lobe could spread anteriorly by several different pathways, above and below the sylvian fissure and medially or laterally. The clinical seizure manifestations would reflect these various spreads. A variable seizure spread pattern was demonstrated in patients with occipital-lobe epilepsy by intracranial recordings by Williamson et a122. An occipitotemporal spread was demonstrated in those patients who had automatisms typical of temporal-lobe seizures and suprasylvian spread was demonstrated in those patients who presented with tonic or clonic motor manifestations, or both. Studies on temporal and spatial characteristics of intracerebral seizure propagation during temporal-lobe epilepsy suggest that frontal regions are more frequently invaded 23. In the current study, frontal lesions demonstrated on imaging presented with generalized seizures, a feature well known to be associated more commonly with frontal than extrafrontal lesions 18, 24. 
